Professor Dimitrios A. Lamprou (Ph.D. MBA) is a subject matter expert in emerging pharmaceutical and biopharmaceutical technologies, with a focus on the development and manufacturing of sustainable drug delivery systems, advanced medical devices, and biocompatible implants. Currently, has authored more than 180 peer-reviewed publications and delivered over 200 invited talks at leading institutions and international conferences. His contributions to pharmaceutics and biomedical engineering have also earned him a place on Stanford University's prestigious list of the world's top 2% of scientists, an honour he has received for several consecutive years. Dr Matthew Wylie (Ph.D.

, MPharm) is a Lecturer in Pharmaceutical Materials Science at the School of Pharmacy, Queen's University Belfast. His research focuses on the design and characterisation of novel stimuli-responsive biomaterials and polymeric functional coatings for drug delivery applications, with a key interest in applying these responsive materials in clinical applications, such as targeted oral drug delivery, and the development of next-generation functional coatings for medical devices and implants. Currently, he has authored over 30 peer-reviewed publications and regularly presents his research at international conferences.